Trial intelligence / Profile preview

Efficacy of Stannous Fluoride Dentifrice in Improving Gingival Health

NCT07704905Completed

Sponsor
Haleon
Start
Jul 2026
Primary completion
Sep 2026
Countries
1
01

Overview

Randomised, single-blind trial of stannous fluoride in gingivitis and dental plaque (2 arms), sponsored by Haleon. Primary endpoint: Overall Modified Gingival Index at 8 weeks. Started Jul 2026; status: completed.

02

Drugs

stannous fluoride
03

Conditions

gingivitisdental plaque

Beyond the preview

Go deeper on NCT07704905.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07704905.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call